-
2
-
-
1242318822
-
State-of-the-art chemotherapy for advanced non-small cell lung cancer
-
Ramalingam S, Belani CP (2004) State-of-the-art chemotherapy for advanced non-small cell lung cancer. Semin Oncol 31:68-74
-
(2004)
Semin. Oncol.
, vol.31
, pp. 68-74
-
-
Ramalingam, S.1
Belani, C.P.2
-
3
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98
-
(2002)
N. Engl. J. Med.
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
-
4
-
-
5444235920
-
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
-
Hotta K, Matsuo K, Ueoka H et al (2004) Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22:3852-3859
-
(2004)
J. Clin. Oncol.
, vol.22
, pp. 3852-3859
-
-
Hotta, K.1
Matsuo, K.2
Ueoka, H.3
-
5
-
-
34347379142
-
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
-
Ardizzoni A, Boni L, Tiseo M et al (2007) Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99:847-857
-
(2007)
J. Natl. Cancer Inst.
, vol.99
, pp. 847-857
-
-
Ardizzoni, A.1
Boni, L.2
Tiseo, M.3
-
6
-
-
0028169602
-
Docetaxel (Taxotere) is active in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group (ECTG)
-
Cerny T, Kaplan S, Pavlidis N et al (1994) Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG). Br J Cancer 70:384-387
-
(1994)
Br. J. Cancer
, vol.70
, pp. 384-387
-
-
Cerny, T.1
Kaplan, S.2
Pavlidis, N.3
-
7
-
-
0028240902
-
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer
-
Francis PA, Rigas JR, Kris MG et al (1994) Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer. J Clin Oncol 12:1232-1237
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 1232-1237
-
-
Francis, P.A.1
Rigas, J.R.2
Kris, M.G.3
-
8
-
-
0029913666
-
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: A Japanese cooperative study
-
Kunitoh H, Watanabe K, Onoshi T et al (1996) Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol 14:1649-1655
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 1649-1655
-
-
Kunitoh, H.1
Watanabe, K.2
Onoshi, T.3
-
9
-
-
23444459189
-
Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer
-
Fossella FV, Lee JS, Murphy WK et al (1994) Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer. J Clin Oncol 12:1238-1244
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 1238-1244
-
-
Fossella, F.V.1
Lee, J.S.2
Murphy, W.K.3
-
10
-
-
0028944053
-
Phase II study of docetaxel (Taxotere) for advanced or metastatic platinum-refractory non-small cell lung cancer
-
Fossella FV, Lee JS, Shin DM et al (1995) Phase II study of docetaxel (Taxotere) for advanced or metastatic platinum-refractory non-small cell lung cancer. J Clin Oncol 13:645-651
-
(1995)
J. Clin. Oncol.
, vol.13
, pp. 645-651
-
-
Fossella, F.V.1
Lee, J.S.2
Shin, D.M.3
-
11
-
-
0033988085
-
Activity of docetaxel in platinum treated non-small-cell lung cancer: Results of a phase II multicenter trial
-
Gandara DR, Vokes E, Green M et al (2000) Activity of docetaxel in platinum treated non-small-cell lung cancer: results of a phase II multicenter trial. J Clin Oncol 18:131-135
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 131-135
-
-
Gandara, D.R.1
Vokes, E.2
Green, M.3
-
12
-
-
0031800526
-
Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
-
Hainsworth JD, Burris HA 3rd, Erland JB et al (1998) Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. J Clin Oncol 16:2164-2168
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 2164-2168
-
-
Hainsworth, J.D.1
Burris III, H.A.2
Erland, J.B.3
-
13
-
-
0032815130
-
Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
-
Briasoulis E, Karavasilis V, Anastasopoulos D et al (1999) Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration. Ann Oncol 10:701-706
-
(1999)
Ann. Oncol.
, vol.10
, pp. 701-706
-
-
Briasoulis, E.1
Karavasilis, V.2
Anastasopoulos, D.3
-
14
-
-
0033735209
-
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
-
Belani CP, Einzig A, Bonomi P et al (2000) Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer. Ann Oncol 11:673-678
-
(2000)
Ann. Oncol.
, vol.11
, pp. 673-678
-
-
Belani, C.P.1
Einzig, A.2
Bonomi, P.3
-
15
-
-
0037348549
-
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
-
Millward MJ, Boyer MJ, Lehnert M et al (2003) Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 14:449-454
-
(2003)
Ann. Oncol.
, vol.14
, pp. 449-454
-
-
Millward, M.J.1
Boyer, M.J.2
Lehnert, M.3
-
16
-
-
0042413836
-
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
-
Fossella F, Pereira JR, von Pawel J et al (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016-3024
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3016-3024
-
-
Fossella, F.1
Pereira, J.R.2
Von Pawel, J.3
-
17
-
-
0024536437
-
Optimal two-stage designs for phase II clinical trials
-
Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10
-
(1989)
Control Clin. Trials
, vol.10
, pp. 1-10
-
-
Simon, R.1
-
18
-
-
0035021152
-
A phase II study of docetaxel and carboplatin in the treatment of nonsmall cell lung cancer
-
Zarogoulidis K, Kontakiotis T, Hatziapostolou P et al (2001) A phase II study of docetaxel and carboplatin in the treatment of nonsmall cell lung cancer. Lung Cancer 32:281-287
-
(2001)
Lung Cancer
, vol.32
, pp. 281-287
-
-
Zarogoulidis, K.1
Kontakiotis, T.2
Hatziapostolou, P.3
-
19
-
-
32244432207
-
A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer
-
DOI 10.1007/s00408-005-2552-5
-
Tsavaris N, Kosmas C, Skopelitis E et al (2005) A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer. Lung 183:405-416 (Pubitemid 43213983)
-
(2005)
Lung
, vol.183
, Issue.6
, pp. 405-416
-
-
Tsavaris, N.1
Kosmas, C.2
Skopelitis, E.3
Gennatas, K.4
Zorbala, A.5
Papas, P.6
Gouveris, P.7
Antypas, G.8
Rokana, S.9
Tzelepis, G.10
-
20
-
-
33750743388
-
A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
-
Kasahara K, Kimura H, Shibata K et al (2006) A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer. Anticancer Res 26:3723-3728
-
(2006)
Anticancer Res.
, vol.26
, pp. 3723-3728
-
-
Kasahara, K.1
Kimura, H.2
Shibata, K.3
-
21
-
-
34247847907
-
Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
-
PII 0124389420061100000010
-
Ishimoto O, Sugawara S, Inoue A et al (2006) Phase II study of carboplatin combined with biweekly docetaxel for advanced nonsmall cell lung cancer. J Thorac Oncol 1:979-983 (Pubitemid 47181366)
-
(2006)
Journal of Thoracic Oncology
, vol.1
, Issue.9
, pp. 979-983
-
-
Ishimoto, O.1
Sugawara, S.2
Inoue, A.3
Ishida, T.4
Munakata, M.5
Koinumaru, S.6
Hasegawa, Y.7
Suzuki, T.8
Miki, H.9
Saijo, Y.10
Nukiwa, T.11
-
22
-
-
0034661693
-
Weekly docetaxel in the treatment of elderly patients will advanced nonsmall cell lung carcinoma: A Minnie Pearl Cancer Research Network Phase II Trial
-
DOI 10.1002/1097-0142(20000715)89:2<328::AID-CNCR17>3.0.CO;2-F
-
Hainsworth JD, Burris HA 3rd, Litchy S et al (2000) Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial. Cancer 89:328-333 (Pubitemid 30489880)
-
(2000)
Cancer
, vol.89
, Issue.2
, pp. 328-333
-
-
Hainsworth, J.D.1
Burris III, H.A.2
Litchy, S.3
Morrissey, L.H.4
Barton, J.H.5
Bradof, J.E.6
Greco, F.A.7
-
23
-
-
34247877762
-
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer
-
Lilenbaum R, Rubin M, Samuel J et al (2007) A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer. J Thorac Oncol 2:306-311
-
(2007)
J. Thorac. Oncol.
, vol.2
, pp. 306-311
-
-
Lilenbaum, R.1
Rubin, M.2
Samuel, J.3
-
24
-
-
9144262313
-
A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
-
Ohe Y, Niho S, Kakinuma R et al (2004) A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients. Ann Oncol 15:45-50
-
(2004)
Ann. Oncol.
, vol.15
, pp. 45-50
-
-
Ohe, Y.1
Niho, S.2
Kakinuma, R.3
-
25
-
-
33750485379
-
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials
-
Bria E, Cuppone F, Ciccarese M et al (2006) Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Cancer Treat Rev 32:583-587
-
(2006)
Cancer Treat Rev.
, vol.32
, pp. 583-587
-
-
Bria, E.1
Cuppone, F.2
Ciccarese, M.3
-
26
-
-
33846849272
-
A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer
-
DOI 10.1097/01.coc.0000242292.17728.46, PII 0000042120070200000010
-
Kaira K, Tsuchiya S, Sunaga N et al (2007) A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer. Am J Clin Oncol 30:51-56 (Pubitemid 46213825)
-
(2007)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.30
, Issue.1
, pp. 51-56
-
-
Kaira, K.1
Tsuchiya, S.2
Sunaga, N.3
Yanagitani, N.4
Watanabe, S.5
Imai, H.6
Hisada, T.7
Ishizuka, T.8
Saito, R.9
Mori, M.10
-
27
-
-
19944430496
-
A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the secondline treatment of non small cell lung cancer. The DISTAL 01 study
-
Gridelli C, Gallo C, Di Maio M et al (2004) A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the secondline treatment of non small cell lung cancer. The DISTAL 01 study. Br J Cancer 91:1996-2004
-
(2004)
Br. J. Cancer
, vol.91
, pp. 1996-2004
-
-
Gridelli, C.1
Gallo, C.2
Di Maio, M.3
-
28
-
-
33644694366
-
Randomized phase III study of 3-weekly vs weekly docetaxel in pretreated advanced non-small-cell lung cancer: A Spanish lung cancer group trial
-
Camps C, Massuti B, Jiménez A et al (2006) Randomized phase III study of 3-weekly vs weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group Trial. Ann Oncol 47:467-472
-
(2006)
Ann. Oncol.
, vol.47
, pp. 467-472
-
-
Camps, C.1
Massuti, B.2
Jiménez, A.3
-
29
-
-
10744223982
-
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
-
Esteban E, González de Sande L, Fernández Y et al (2003) Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. Ann Oncol 14:1640-1647
-
(2003)
Ann. Oncol.
, vol.14
, pp. 1640-1647
-
-
Esteban, E.1
De Sande, G.L.2
Fernández, Y.3
|